Buy & Sell QUALCOMM, Inc. (QCOM) – QUALCOMM, Inc. Price Today
Aura AI Summary
Key Stats
- $206.17BMarket Cap
- TechnologySector
- -17.65%3M Drawdown
- $211.64BEnterprise Value
- 1.88%Dividend Yield
- 61% Buy | 39% SellTrading Activity
- 93 daysTypical Hold Time
QUALCOMM, Inc. (QCOM) is currently valued at a market capitalization of $206.17B, with an enterprise value of $211.64B. Over the past 52 weeks, QUALCOMM, Inc. has traded between a low of $124.07 and a high of $237.53, highlighting its annual price range. Over the past three months, QUALCOMM, Inc. has recorded a drawdown of -17.65%, reflecting recent price volatility. QUALCOMM, Inc. offers a dividend yield of 1.88%, with the most recent dividend of $0.89 paid on 05 Mar 26. On average, investors hold QUALCOMM, Inc. for approximately 93 days, indicating typical investor behavior on the platform.
About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Most Recent News
BC launches Outdoor Sector Coalition to boost economy, health, and conservation of its outdoors.
A coalition of over 2,000 organizations in British Columbia has formed to support the province's outdoor sector, which is a $17 billion industry employing 80,000 people. The coalition aims to enhance health benefits, support outdoor businesses, and p...

ESR1-mutated metastatic breast cancer market to grow 9.6% CAGR with new oral SERDs and targeted therapies.
The ESR1-mutated metastatic breast cancer market is projected to grow rapidly at a 9.6% CAGR from 2026 to 2036, driven by rising cases of endocrine-resistant HR-positive/HER2-negative breast cancer and advances in precision oncology. Novel therapies ...

Exosens doubles cooled infrared camera production to meet rising demand in counter-drone systems.
Exosens plans to double its production capacity for cooled infrared cameras in 2026 to meet growing global demand, especially for long-range surveillance and counter-drone applications. These cameras, made in France, are critical for detecting drone ...
